Red blood cell specifications for patients with hemoglobinopathies: a systematic review and guideline
Transfus; 58 (6), 2018
BACKGROUND
Red blood cell (RBC) transfusions remain essential in the treatment of patients with sickle cell disease (SCD) and β‐thalassemia. Alloimmunization, a well‐documented complication of transfusion, increases the risk of delayed hemolytic transfusion reactions, complicates crossmatching and i...
Drépanocytose, Transfusion d'érythrocytes/22074, Hémoglobinopathies/thérapie, Réaction transfusionnelle/prévention et contrôle, Réaction transfusionnelle, bêta-Thalassémie/thérapie, Drépanocytose/thérapie, Érythrocytes/métabolisme, Drépanocytose/traitement médicamenteux, Transfusion d'érythrocytes, Alloanticorps/usage thérapeutique, Isoantigènes/usage thérapeutique